Microsporidian infection disrupts gut microbiome and drives metabolic dysregulation in Macrobrachium nipponense.

Comp Biochem Physiol Part D Genomics Proteomics

Institute of Aquatic Biology and Jiangsu Key Laboratory for Biofunctional Molecules, College of Life Sciences and Chemistry, Jiangsu Second Normal University, Nanjing 210013, China.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The gut microbiome plays a crucial role in maintaining host health, yet its functions in aquatic animals remain incompletely understood. Given its economic significance in Asian aquaculture, the oriental river prawn (Macrobrachium nipponense) was chosen to assess microbiome dynamics during infection with Potaspora macrobrachium, an emerging microsporidian pathogen. Histopathological analysis confirmed severe microsporidian infections in diseased prawns. Using 16S rRNA gene sequencing (Illumina MiSeq), we characterized infection-induced shifts in the gut microbiome's composition and structure. Bacterial communities showed significant divergence between health states, with infection status being the primary clustering determinant. The microbiome was dominated by Proteobacteria (86.4 %), Bacteroidota (6.89 %), Firmicutes (3.41 %), and Actinobacteriota (1.69 %), displaying distinct abundance patterns. Disease-state indicators included Rikenellaceae, Pseudomonas oryzihabitans, and Bacteroides fragilis among others. Critically, functional prediction revealed that metabolic pathways, particularly carbohydrate metabolism, amino acid metabolism, and cofactor/vitamin metabolism, were significantly altered in infected prawns, suggesting that P. macrobrachium infection reprograms the metabolic activity of the gut microbiome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cbd.2025.101589DOI Listing

Publication Analysis

Top Keywords

gut microbiome
12
macrobrachium nipponense
8
microbiome
5
microsporidian infection
4
infection disrupts
4
gut
4
disrupts gut
4
microbiome drives
4
drives metabolic
4
metabolic dysregulation
4

Similar Publications

The ameliorative effect of Lactiplantibacillus plantarum SCS2 on DSS-induced murine colitis.

Arch Microbiol

September 2025

School of Public Health, Chengdu University of Traditional Chinese Medicine, No. 1166, Liutai Avenue, Wenjiang District, Chengdu, 611137, Sichuan Province, China.

The inhibitory effects of Lactiplantibacillus plantarum on inflammatory responses are known, but its action mechanisms in oxidative stress, immunomodulation, and intestinal homeostasis remain of interest. Accordingly, we investigated the protective effects of Lactiplantibacillus plantarum SCS2 (L. plantarum SCS2) against sodium dextran sulfate (DSS)-induced colitis in mice as well as elucidated its impact on inflammation, oxidative stress, and intestinal microbiota.

View Article and Find Full Text PDF

16S rRNA metagenome analysis of gut bacteriome of Rohu () from Halda River and Kaptai Lake, Bangladesh.

Microbiol Resour Announc

September 2025

Department of Genomics and Bioinformatics, Faculty of Biotechnology and Genetic Engineering, Chattogram Veterinary and Animal Sciences University (CVASU), Chattogram, Bangladesh.

This research evaluated the gut microbiota of Rohu fish from the Halda River and Kaptai Lake in Bangladesh by 16S rRNA sequencing. Distinct microbial profiles were identified, with Halda samples concentrated in pathogens and Kaptai samples abundant in probiotics.

View Article and Find Full Text PDF

Rifaximin reduces gut-derived inflammation in severe acute pancreatitis: an experimental animal model and randomized controlled trial.

Microbiol Spectr

September 2025

Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Unlabelled: Severe acute pancreatitis (SAP) is characterized by systemic inflammation and intestinal barrier dysfunction and is often associated with gut microbiota dysbiosis. Rifaximin, a gut-specific non-absorbable antibiotic, is known to modulate the gut microbiota. Here, we investigated rifaximin's effects and mechanisms in SAP using murine models and a single-center, open-label, randomized controlled trial (Chinese Clinical Trial Registry: ChiCTR2100049794).

View Article and Find Full Text PDF

Gut dysbiosis and an increased risk of respiratory infection in type 2 diabetes have been well recognised. However, the relationship between the gut and respiratory pathobionts carriage rate in the Type 2 diabetic Malaysian population is understudied. To address the knowledge gap, we profiled the gut and upper respiratory tract microbial composition, as well as the urine metabolome of 31 type 2 diabetic adults and 14 non-diabetes adults.

View Article and Find Full Text PDF